Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Florbetaben PET Imaging in Primary Progressive Aphasia

NCT04720001 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT04720001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04720001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Florbetaben PET Imaging in Primary Progressive Aphasia
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Completed
Start date
August 23, 2018
Completion date
February 26, 2021
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, primary progressive aphasia